References: Initial pharmacotherapy for major depression in children

  • Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet 2018;391(10128):1357–66. https://www.ncbi.nlm.nih.gov/pubmed/29477251
  • Davey CG, Chanen AM, Hetrick SE, Cotton SM, Ratheesh A, Amminger GP, et al. The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial. Lancet Psychiatry 2019;6(9):735–44. https://www.ncbi.nlm.nih.gov/pubmed/31371212
  • Eapen V, Crncec R. Strategies and challenges in the management of adolescent depression. Curr Opin Psychiatry 2012;25(1):7–13. https://www.ncbi.nlm.nih.gov/pubmed/22156932
  • Goodyer I, Dubicka B, Wilkinson P, Kelvin R, Roberts C, Byford S, et al. Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trial. BMJ 2007;335(7611):142. https://www.ncbi.nlm.nih.gov/pubmed/17556431
  • Jane Garland E, Kutcher S, Virani A, Elbe D. Update on the use of SSRIs and SNRIs with children and adolescents in clinical practice. J Can Acad Child Adolesc Psychiatry 2016;25(1):4–10. https://www.ncbi.nlm.nih.gov/pubmed/27047551
  • Korczak DJ, Canadian Paediatric Society, Mental Health and Developmental Disabilities Committee. Use of selective serotonin reuptake inhibitor medications for the treatment of child and adolescent mental illness. Paediatrics & Child Health 2013;18(9):487–91. https://doi.org/10.1093/pch/18.9.487
  • Le Noury J, Nardo JM, Healy D, Jureidini J, Raven M, Tufanaru C, et al. Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence. BMJ 2015;351:h4320. https://www.ncbi.nlm.nih.gov/pubmed/26376805
  • Malhi GS, Bassett D, Boyce P, Bryant R, Fitzgerald PB, Fritz K, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry 2015;49(12):1087–206. https://www.ncbi.nlm.nih.gov/pubmed/26643054
  • Zhou X, Teng T, Zhang Y, Del Giovane C, Furukawa TA, Weisz JR, et al. Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis. Lancet Psychiatry 2020;7(7):581–601. https://www.ncbi.nlm.nih.gov/pubmed/32563306